Posters

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29

Sunday, September 27

3:00 PM - 4:00 PM ET

2220 - Neoadjuvant Radiotherapy Combined with Lenvatinib and Sintilimab in Patients with Resectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: An Open-Label, Single-Arm, Multicenter, Prospective Phase I Clinical Trial
Speaker: Shu, Bin - Hepatopancereatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing
3:00 PM - 4:00 PM ET

2221 - External Beam Radiotherapy for Gastroenteropancreatic Neuroendocrine Neoplasms: Long-Term Local Control, Survival and Toxicity
Speaker: Shuai, Jiacheng, MD - Peking Union Medical College Hospital, Beijing, Beijing
3:00 PM - 4:00 PM ET

2222 - Treatment Mode and Prognostic Factors of Radiotherapy-Related Esophageal Fistula in Patients with Eesophageal Squamous Cell Carcinoma: A Retrospective Cohort Study
Speaker: Si, Hanyu, MD, MB - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei
3:00 PM - 4:00 PM ET

2223 - Association of Pancreatic Cancer Resection and Post-recurrence Disease Course
Speaker: Silberstein, Alice, MD - Harvard Radiation Oncology Program, Boston, MA
3:00 PM - 4:00 PM ET

2224 - The Pediatric AVM Experience
Speaker: Simpson, Andrew, MD - UAB Radiation Oncology, Birmingham, AL
3:00 PM - 4:00 PM ET

2225 - Locoregional Treatment Outcomes of Hepatocellular Carcinoma Defined by Large Tumor Size or Macrovascular Invasion with Yttrium-90 Radioembolization and Stereotactic Body Radiation Therapy
Speaker: Singh, Abhiram - UCLA, Los Angeles, CA
3:00 PM - 4:00 PM ET

2226 - TRIB1 Interacts with HDAC1 in GBM Cells and Modulates p53 Activity in Response to Radiation Treatment
Speaker: Singh, Karnika, PhD, MBA - OSU CCC, Columbus, OH
3:00 PM - 4:00 PM ET

2227 - Outcomes Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Single Institution Experience
Speaker: Skipper, Andrew, MD - Duke University Health System, Durham, NC
3:00 PM - 4:00 PM ET

2228 - Multi-Institutional Analysis of Dose and Factors Associated with All Cause Morbidity after Stereotactic Radiotherapy for Intact Melanoma Brain Metastases
Speaker: Snyder, Owen, BA - University of Cincinnati College of Medicine, Cincinnati, OH
3:00 PM - 4:00 PM ET

2229 - Stereotactic Body Radiation Therapy for the Treatment of Spinal Chordomas - A Single Institutional Retrospective Review
Speaker: Song, Grace, BA - Cleveland Clinic Foundation, Cleveland, OH
3:00 PM - 4:00 PM ET

2230 - Efficacy and Safety of Fractionated Stereotactic Radiosurgery for the Treatment of Large Intracranial Arteriovenous Malformations
Speaker: Vaios, Eugene, MD, MBA - Duke Cancer Institute, Durham, NC
3:00 PM - 4:00 PM ET

2231 - Clinical Outcomes of Gamma Knife Lightning for Brain Metastases: Consistent Local Control but Size-Dependent Radionecrosis, Influenced By Dosimetric Shifts and Clinician Planning Priorities
Speaker: Starner, John, DO - Northwell Health, Lake Success, NY